Small fibers in Fabry disease: Baseline and follow-up data under enzyme replacement therapy

Journal of the Peripheral Nervous System

Volumn 16, Issue 4, 2011, Pages 304-314

  Üçeyler, Nurcan ^a   He, Lan ^a,c   Schönfeld, Dorothee ^a   Kahn, Ann Kathrin ^a   Reiners, Karlheinz ^a   Hilz, Max J ^b   Breunig, Frank ^a,d   Sommer, Claudia ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^d KfH Center for Dialysis and Kidney Transplantation   (Germany)

Author keywords

enzyme replacement therapy; Fabry disease; skin biopsy; small fiber neuropathy

Indexed keywords

AGALSIDASE ALFA; AGALSIDASE BETA; CYTOKINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; ELECTROPHYSIOLOGY; ENZYME REPLACEMENT; FABRY DISEASE; FEMALE; FOLLOW UP; GENE EXPRESSION; HUMAN; HUMAN TISSUE; KIDNEY DYSFUNCTION; MALE; NERVE CONDUCTION; NERVE FIBER; NEUROPATHIC PAIN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SENSORY ANALYSIS; SKIN BIOPSY; SURAL NERVE; TEMPERATURE SENSITIVITY; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; ALPHA-GALACTOSIDASE; ELECTROPHYSIOLOGY; ENZYME REPLACEMENT THERAPY; FABRY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; NERVE FIBERS; PERIPHERAL NERVOUS SYSTEM DISEASES; SKIN; YOUNG ADULT;

EID: 83755184167     PISSN: 10859489     EISSN: 15298027     Source Type: Journal    
DOI: 10.1111/j.1529-8027.2011.00365.x     Document Type: Article

References (32)

1. Boucek P, Havrdova T, Voska L, Lodererova A, He L, Saudek F, Lipar K, Adamec M, Sommer C, (2008). Epidermal innervation in type 1 diabetic patients: a 2.5-year prospective study after simultaneous pancreas/kidney transplantation. Diabetes Care 31: 1611-1612.
2. Bouhassira D, Attal N, Fermanian J, Alchaar H, Gautron M, Masquelier E, Rostaing S, Lanteri-Minet M, Collin E, Grisart J, Boureau F, (2004). Development and validation of the Neuropathic Pain Symptom Inventory. Pain 108: 248-257. (Pubitemid 38353047)
3. Dutsch M, Marthol H, Stemper B, Brys M, Haendl T, Hilz MJ, (2002). Small fiber dysfunction predominates in Fabry neuropathy. J Clin Neurophysiol 19: 575-586. (Pubitemid 36008382)
4. Galanos J, Nicholls K, Grigg L, Kiers L, Crawford A, Becker G, (2002). Clinical features of Fabry's disease in Australian patients. Intern Med J 32: 575-584. (Pubitemid 36871740)
5. Gemignani F, Marbini A, Bragaglia MM, Govoni E, (1984). Pathological study of the sural nerve in Fabry's disease. Eur Neurol 23: 173-181. (Pubitemid 14086950)
6. Hahn K, Triolo A, Hauer P, McArthur JC, Polydefkis M, (2007). Impaired reinnervation in HIV infection following experimental denervation. Neurology 68: 1251-1256. (Pubitemid 46625969)
7. Hilz MJ, Axelrod FB, Bickel A, Stemper B, Brys M, Wendelschafer-Crabb G, Kennedy WR, (2004a). Assessing function and pathology in familial dysautonomia: assessment of temperature perception, sweating and cutaneous innervation. Brain 127: 2090-2098. (Pubitemid 39150266)
8. Hilz MJ, Brys M, Marthol H, Stemper B, Dutsch M, (2004b). Enzyme replacement therapy improves function of C-, Adelta-, and Abeta-nerve fibers in Fabry neuropathy. Neurology 62: 1066-1072. (Pubitemid 38456498)
9. Kennedy WR, (2004). Unmyelinated nerves, challenges, and opportunities: skin biopsy and beyond. Suppl Clin Neurophysiol 57: 8-14.
10. Laaksonen SM, Roytta M, Jaaskelainen SK, Kantola I, Penttinen M, Falck B, (2008). Neuropathic symptoms and findings in women with Fabry disease. Clin Neurophysiol 119: 1365-1372.
11. Liguori R, Di Stasi V, Bugiardini E, Mignani R, Burlina A, Borsini W, Baruzzi A, Montagna P, Donadio V, (2010). Small fiber neuropathy in female patients with fabry disease. Muscle Nerve 41: 409-412.
12. Low M, Nicholls K, Tubridy N, Hand P, Velakoulis D, Kiers L, Mitchell P, Becker G, (2007). Neurology of Fabry disease. Intern Med J 37: 436-447. (Pubitemid 46855079)
13. Luciano CA, Russell JW, Banerjee TK, Quirk JM, Scott LJ, Dambrosia JM, Barton NW, Schiffmann R, (2002). Physiological characterization of neuropathy in Fabry's disease. Muscle Nerve 26: 622-629. (Pubitemid 35266085)
14. Maag R, Binder A, Baron R, (2008). Assessment of pain and somatosensory function in Fabry disease: early diagnosis. Clin Ther 30 Suppl B: S52-S53. (Pubitemid 351458361)
15. McCarthy BG, Hsieh ST, Stocks A, Hauer P, Macko C, Cornblath DR, Griffin JW, McArthur JC, (1995). Cutaneous innervation in sensory neuropathies: evaluation by skin biopsy. Neurology 45: 1848-1855. (Pubitemid 27122956)
16. Nodera H, Barbano RL, Henderson D, Herrmann DN, (2003). Epidermal reinnervation concomitant with symptomatic improvement in a sensory neuropathy. Muscle Nerve 27: 507-509. (Pubitemid 36397072)
17. Radloff LS, (1977). The CES-D: a self-report symptom scale to detect depression in the general population. Appl Psychol Meas 3: 385-401.
18. Rolke R, Baron R, Maier C, Tölle TR, Treede RD, Beyer A, Binder A, Birbaumer N, Birklein F, Botefur IC, Braune S, Flor H, Huge V, Klug R, Landwehrmeyer GB, Magerl W, Maihofner C, Rolko C, Schaub C, Scherens A, Sprenger T, Valet M, Wasserka B, (2006). Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values. Pain 123: 231-243.
19. Schiffmann R, Floeter MK, Dambrosia JM, Gupta S, Moore DF, Sharabi Y, Khurana RK, Brady RO, (2003). Enzyme replacement therapy improves peripheral nerve and sweat function in Fabry disease. Muscle Nerve 28: 703-710. (Pubitemid 37484832)
20. Schiffmann R, Hauer P, Freeman B, Ries M, Scott LJ, Polydefkis M, Brady RO, McArthur JC, Wagner K, (2006). Enzyme replacement therapy and intraepidermal innervation density in Fabry disease. Muscle Nerve 34: 53-56.
21. Schiffmann R, Warnock DG, Banikazemi M, Bultas J, Linthorst GE, Packman S, Sorensen SA, Wilcox WR, Desnick RJ, (2009). Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy. Nephrol Dial Transplant 24: 2102-2111.
22. Scott LJ, Griffin JW, Luciano C, Barton NW, Banerjee T, Crawford T, McArthur JC, Tournay A, Schiffmann R, (1999). Quantitative analysis of epidermal innervation in Fabry disease. Neurology 52: 1249-1254. (Pubitemid 29177930)
23. Sommer C, Richter H, Rogausch JP, Frettlöh J, Lungenhausen M, Maier C, (2011). A modified score to identify and discriminate neuropathic pain: a study on the German version of the Neuropathic Pain Symptom Inventory (NPSI). BMC Neurol 11: 104.
24. Sima AA, Robertson DM, (1978). Involvement of peripheral nerve and muscle in Fabry's disease. Histologic, ultrastructural, and morphometric studies. Arch Neurol 35: 291-301. (Pubitemid 8311543)
25. Syed NA, Sandbrink F, Luciano CA, Altarescu G, Weibel T, Schiffmann R, Floeter MK, (2000). Cutaneous silent periods in patients with Fabry disease. Muscle Nerve 23: 1179-1186. (Pubitemid 30602236)
26. Tahir H, Jackson LL, Warnock DG, (2007). Antiproteinuric therapy and Fabry nephropathy: sustained reduction of proteinuria in patients receiving enzyme replacement therapy with agalsidase-beta. J Am Soc Nephrol 18: 2609-2617. (Pubitemid 47378878)
27. Tavakoli M, Marshall A, Thompson L, Kenny M, Waldek S, Efron N, Malik RA, (2009). Corneal confocal microscopy: a novel noninvasive means to diagnose neuropathy in patients with Fabry disease. Muscle Nerve 40: 976-984.
28. Torvin Moller A, Winther Bach F, Feldt-Rasmussen U, Rasmussen A, Hasholt L, Lan H, Sommer C, Kolvraa S, Ballegaard M, Staehelin Jensen T, (2009). Functional and structural nerve fiber findings in heterozygote patients with Fabry disease. Pain 145: 237-245.
29. Üçeyler N, Kafke W, Riediger N, He L, Necula G, Toyka KV, Sommer C, (2010). Elevated proinflammatory cytokine expression in affected skin in small fiber neuropathy. Neurology 74: 1806-1813.
30. Vedder AC, Linthorst GE, Houge G, Groener JE, Ormel EE, Bouma BJ, Aerts JM, Hirth A, Hollak CE, (2007). Treatment of Fabry disease: outcome of a comparative trial with agalsidase alfa or beta at a dose of 0.2 mg/kg. PLoS ONE 2: e598.
31. Von Korff M, Ormel J, Keefe FJ, Dworkin SF, (1992). Grading the severity of chronic pain. Pain 50: 133-149.
32. Zarate YA, Hopkin RJ, (2008). Fabry's disease. Lancet 372: 1427-1435.